We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

56 hedge funds and large institutions have $146M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

180% more funds holding

Funds holding: 20 → 56 (+36)

104% more capital invested

Capital invested by funds: $71.9M → $146M (+$74.6M)

Holders
56
Holders Change
+36
Holders Change %
+180%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
5
Reduced
1
Closed
2
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
+$100K

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$9.93M
2
PC
Periscope Capital
Ontario, Canada
+$6.97M
3
LA
Linden Advisors
New York
+$6.95M
4
SC
Sculptor Capital
New York
+$4.97M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.24M

Top Sellers

Rank Fund Capital Flow
1
NAM
Nexpoint Asset Management
Texas
-$2.57M
2
HCM
Highbridge Capital Management
New York
-$2.25M
3
CS
Clear Street
New York
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
26
Whitebox Advisors
Minnesota
$2M +$1.99M +200,000 New
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$2M – – –
AIMCA
28
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2M +$1.99M +200,000 New
JP Morgan Chase
29
JP Morgan Chase
New York
$1.99M +$1.98M +198,900 New
CCM
30
Context Capital Management
California
$1.35M +$1.34M +135,339 New
CH
31
CVI Holdings
Delaware
$1.2M +$1.19M +119,885 New
Walleye Capital
32
Walleye Capital
New York
$1.13M +$1.12M +112,969 New
SV
33
Starboard Value
New York
$1.07M +$106K +10,693 +11%
OCM
34
Oaktree Capital Management
California
$999K – – –
DKCM
35
Davidson Kempner Capital Management
New York
$999K +$993K +100,000 New
WAM
36
Wolverine Asset Management
Illinois
$945K +$840K +84,573 +846%
Walleye Trading
37
Walleye Trading
New York
$630K +$626K +63,000 New
Citigroup
38
Citigroup
New York
$500K +$497K +50,001 New
KC
39
Kryger Capital
United Kingdom
$441K +$438K +44,083 New
DAM
40
DLD Asset Management
New York
$432K +$430K +43,250 New
LCM
41
Lynwood Capital Management
Ontario, Canada
$315K +$312K +31,454 New
BFM
42
Boothbay Fund Management
New York
$315K +$313K +31,494 New
GCL
43
Glazer Capital LLC
New York
$311K +$308K +31,056 New
CC
44
Centiva Capital
New York
$299K +$297K +29,891 New
SAMU
45
SONA Asset Management (US)
New York
$299K +$298K +30,000 New
DCM
46
Dupont Capital Management
Delaware
$250K – – –
WP
47
Woodline Partners
California
$250K +$248K +25,000 New
PP
48
Paloma Partners
Connecticut
$200K +$199K +20,000 New
Capstone Investment Advisors
49
Capstone Investment Advisors
New York
$100K +$99.3K +10,000 New
USPCM
50
Union Square Park Capital Management
New York
$100K +$99.3K +10,000 New
1
2
3

IQMD Hedge Fund Activity: Q1 2022 in Review

56 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2022, worth a combined $146M — up 104% from $71.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IQMD positions and 2 closed out — a net gain of 36 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $9.93M. The largest seller was Nexpoint Asset Management, exiting entirely with an estimated $2.57M sold.

  • 56 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2022, up from 20 in Q4 2021.
  • Funds reported $146M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2022, up 104% quarter-over-quarter.
  • 38 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +36 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2022 was MMCAP International, an estimated $9.93M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2022 was Nexpoint Asset Management, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2022.